Health Condition 1: C710- Malignant neoplasm of cerebrum, except lobes and ventricles Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Bilateral scalp blocks for supratentorial craniotomy: Bilateral scalp blocks for supratentorial craniotomy with plain 0.25% (maximum dose 2mg/kg) and addition of injection Clonidine 2mc
Sponsors
Dr Chris Lemos
Eligibility
Inclusion criteria
Inclusion criteria: ASA I and II GCS 15
Exclusion criteria
Exclusion criteria: GCS Pregnant patients Allergy to any of the study drugs h/o Diabetes Mellitus h/o hypertension Emergency cases Pre-op bradycardia h/o ischemic heart diease/arrhythmias patient refusal to participate in the study Previous history of craniotomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.intraoperative anaesthetic requirements 2.intra-operative hemodynamic responseTimepoint: 1.intraoperative anaesthetic requirements 2.intra-operative hemodynamic response | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare duration of post operative analgesia provided by local anaesthetic bupivacaine in scalp blocks with clonidine as an adjuvant to bupivacaine in patients undergoing supratentorial craniotomyTimepoint: VRS score every 4 fours upto first 24 hours in post operative period | — |
Countries
India
Contacts
Public ContactDr Chris Lemos
Superspeciality hospital NSCB Medical college Jabalpur
Outcome results
None listed